Peer Review reports
From: The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
| Original Submission | ||
|---|---|---|
| 16 Aug 2021 | Submitted | Original manuscript |
| 13 Oct 2021 | Reviewed | Reviewer Report |
| 22 Nov 2021 | Reviewed | Reviewer Report |
| 18 Dec 2021 | Author responded | Author comments - Jie Dong |
| 6 Jan 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 2 | ||
| 18 Dec 2021 | Submitted | Manuscript version 2 |
| 21 Jan 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 3 | ||
| 21 Jan 2022 | Submitted | Manuscript version 3 |
| 2 Feb 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 4 | ||
| 2 Feb 2022 | Submitted | Manuscript version 4 |
| 22 Feb 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 5 | ||
| 22 Feb 2022 | Submitted | Manuscript version 5 |
| 14 Mar 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 6 | ||
| 14 Mar 2022 | Submitted | Manuscript version 6 |
| 4 Apr 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 7 | ||
| 4 Apr 2022 | Submitted | Manuscript version 7 |
| 14 Apr 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 8 | ||
| 14 Apr 2022 | Submitted | Manuscript version 8 |
| 16 Apr 2022 | Author responded | Author comments - Jie Dong |
| Resubmission - Version 9 | ||
| 16 Apr 2022 | Submitted | Manuscript version 9 |
| Publishing | ||
| 24 May 2022 | Editorially accepted | |
| 4 Jun 2022 | Article published | 10.1186/s12865-022-00502-7 |
You can find further information about peer review here.